Meanwhile, miR-493 played an oncogenic role in GC by directly targeting DKK1. Our results provide new insight into the role of miR-493/DKK1 signaling pathway in GC progression and suggest potential molecular target for the treatment of GC. Here, DKK1 is linked to gastric cancer.